Lataa...
Histone deacetylase inhibitors: emerging mechanisms of resistance
The histone deacetylase inhibitors (HDIs) have shown promise in the treatment of a number of hematologic malignancies, leading to the approval of vorinostat and romidepsin for the treatment of cutaneous T-cell lymphoma and romidepsin for the treatment of peripheral T-cell lymphoma by the U. S. Food...
Tallennettuna:
| Päätekijät: | , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2011
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3230675/ https://ncbi.nlm.nih.gov/pubmed/21899343 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/mp200329f |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|